S. C. R. No. 10 As Reported by the House Health and Aging Committee

As Reported by the House Health and Aging Committee

130th General Assembly

Regular Session

2013-2014

S. C. R. No. 10

Senator Burke

Cosponsors: Senators Brown, Gardner, Tavares, Bacon, Balderson, Beagle, Coley, Eklund, Faber, Hite, Hughes, Jones, Kearney, LaRose, Lehner, Manning, Obhof, Oelslager, Patton, Peterson, Sawyer, Schaffer, Seitz, Skindell, Smith, Uecker, Widener
Representatives Wachtmann, Barnes, Bishoff, Carney, Hottinger, Ramos, Schuring, Smith

A CONCURRENT RESOLUTION

To memorialize the Congress of the United States to 1
seek the withdrawal of the United States 2
Preventive Services Task Force recommendation 3
against prostate-specific antigen-based screening 4
for prostate cancer for men in all age groups. 5

BE IT RESOLVED BY THE SENATE OF THE STATE OF OHIO
(THE HOUSE OF REPRESENTATIVES CONCURRING):

       WHEREAS, The United States Preventive Services Task Force 6
(USPSTF) is an independent panel of nonfederal experts in 7
prevention and evidence-based medicine that is composed of primary 8
care physicians; and 9

       WHEREAS, The USPSTF members are appointed by the United 10
States Department of Health and Human Services to conduct 11
scientific evidence reviews of a broad range of clinical health 12
care preventive services and develop recommendations for primary 13
care clinicians and health systems; and 14

       WHEREAS, The USPSTF acknowledges that prostate cancer is the 15
most commonly diagnosed nonskin cancer in men in the United 16
States, with one in six American men being diagnosed with prostate 17
cancer in his lifetime; and 18

       WHEREAS, Prostate cancer is the second leading cause of 19
cancer-related deaths in men in the United States; and 20

       WHEREAS, The American Cancer Society estimates that in 2013 21
approximately 238,590 men in the United States will be diagnosed 22
with prostate cancer and 29,720 men will die from the disease; and 23

       WHEREAS, In Ohio alone, there are approximately 7,961 newly 24
diagnosed cases of prostate cancer and 1,232 deaths from the 25
disease on an annual basis, according to the February 2011 report 26
issued by the Ohio Cancer Incidence Surveillance System; and 27

       WHEREAS, In 2008, the USPSTF recommended against 28
prostate-specific antigen-based screening for prostate cancer for 29
men ages 75 and older; and 30

       WHEREAS, In October 2011, the USPSTF issued a new 31
recommendation against prostate-specific antigen-based screening 32
for prostate cancer for men in all age groups, because it 33
concluded that there is moderate or high certainty that the 34
service has no net benefit or that the harms outweigh the 35
benefits; and 36

       WHEREAS, The USPSTF states that the October 2011 37
recommendation applies to men in the United States who do not have 38
symptoms of prostate cancer, even though by the time a man 39
experiences symptoms of prostate cancer, the cancer is generally 40
too advanced to cure; and 41

       WHEREAS, The USPSTF states that its recommendation against 42
screening applies regardless of race, even though the USPSTF 43
acknowledges that African-American men have a substantially higher 44
prostate cancer incidence rate than Caucasian men and more than 45
twice the prostate cancer mortality rate of Caucasian men; and 46

       WHEREAS, The USPSTF issued this recommendation without having 47
a urologist or oncologist, two types of physicians who specialize 48
in diagnosing and treating patients with prostate cancer, on the 49
task force; and 50

       WHEREAS, The USPSTF's 2011 recommendation regarding prostate 51
cancer screening follows its recommendation in November 2009 52
against routine mammograms for women ages 40 to 49 and against 53
teaching women to do breast self-examinations, which Congress 54
rejected after public outcry; and 55

       WHEREAS, The most recently updated study, the Goteborg 56
Randomized Population-based Prostate Cancer Screening Trial, found 57
that with screening, deaths from prostate cancer dropped 44 per 58
cent over a 14-year period, compared with men who did not undergo 59
screening, and that prostate cancer screening efficiency was 60
similar to other cancers; and 61

       WHEREAS, The USPSTF recommendation against screening puts 62
into harm's way men who are most at risk: the underinsured, those 63
who live in areas where health care is not readily available, 64
those who have a family history of prostate cancer, and 65
African-American men, who have a higher incidence of and higher 66
mortality rate from prostate cancer than Caucasian men; now 67
therefore be it 68

       RESOLVED, That we, the members of the 130th General Assembly 69
of the State of Ohio, in adopting this resolution, respectfully 70
memorialize the Congress of the United States to seek the 71
withdrawal of the United States Preventive Services Task Force 72
recommendation against prostate-specific antigen-based screening 73
for prostate cancer for men in all age groups; and be it further 74

       RESOLVED, That the Clerk of the Senate transmit duly 75
authenticated copies of this resolution to each member of the Ohio 76
Congressional delegation. 77

WHEREAS, The United States Preventive Services Task Force	6
(USPSTF) is an independent panel of nonfederal experts in	7
prevention and evidence-based medicine that is composed of primary	8
care physicians; and	9

WHEREAS, The USPSTF members are appointed by the United	10
States Department of Health and Human Services to conduct	11
scientific evidence reviews of a broad range of clinical health	12
care preventive services and develop recommendations for primary	13
care clinicians and health systems; and	14

WHEREAS, The USPSTF acknowledges that prostate cancer is the	15
most commonly diagnosed nonskin cancer in men in the United	16
States, with one in six American men being diagnosed with prostate	17
cancer in his lifetime; and	18

WHEREAS, Prostate cancer is the second leading cause of	19
cancer-related deaths in men in the United States; and	20

WHEREAS, The American Cancer Society estimates that in 2013	21
approximately 238,590 men in the United States will be diagnosed	22
with prostate cancer and 29,720 men will die from the disease; and	23

WHEREAS, In Ohio alone, there are approximately 7,961 newly	24
diagnosed cases of prostate cancer and 1,232 deaths from the	25
disease on an annual basis, according to the February 2011 report	26
issued by the Ohio Cancer Incidence Surveillance System; and	27

WHEREAS, In 2008, the USPSTF recommended against	28
prostate-specific antigen-based screening for prostate cancer for	29
men ages 75 and older; and	30

WHEREAS, In October 2011, the USPSTF issued a new	31
recommendation against prostate-specific antigen-based screening	32
for prostate cancer for men in all age groups, because it	33
concluded that there is moderate or high certainty that the	34
service has no net benefit or that the harms outweigh the	35
benefits; and	36

WHEREAS, The USPSTF states that the October 2011	37
recommendation applies to men in the United States who do not have	38
symptoms of prostate cancer, even though by the time a man	39
experiences symptoms of prostate cancer, the cancer is generally	40
too advanced to cure; and	41

WHEREAS, The USPSTF states that its recommendation against	42
screening applies regardless of race, even though the USPSTF	43
acknowledges that African-American men have a substantially higher	44
prostate cancer incidence rate than Caucasian men and more than	45
twice the prostate cancer mortality rate of Caucasian men; and	46

WHEREAS, The USPSTF issued this recommendation without having	47
a urologist or oncologist, two types of physicians who specialize	48
in diagnosing and treating patients with prostate cancer, on the	49
task force; and	50

WHEREAS, The USPSTF's 2011 recommendation regarding prostate	51
cancer screening follows its recommendation in November 2009	52
against routine mammograms for women ages 40 to 49 and against	53
teaching women to do breast self-examinations, which Congress	54
rejected after public outcry; and	55

WHEREAS, The most recently updated study, the Goteborg	56
Randomized Population-based Prostate Cancer Screening Trial, found	57
that with screening, deaths from prostate cancer dropped 44 per	58
cent over a 14-year period, compared with men who did not undergo	59
screening, and that prostate cancer screening efficiency was	60
similar to other cancers; and	61

WHEREAS, The USPSTF recommendation against screening puts	62
into harm's way men who are most at risk: the underinsured, those	63
who live in areas where health care is not readily available,	64
those who have a family history of prostate cancer, and	65
African-American men, who have a higher incidence of and higher	66
mortality rate from prostate cancer than Caucasian men; now	67
therefore be it	68

RESOLVED, That we, the members of the 130th General Assembly	69
of the State of Ohio, in adopting this resolution, respectfully	70
memorialize the Congress of the United States to seek the	71
withdrawal of the United States Preventive Services Task Force	72
recommendation against prostate-specific antigen-based screening	73
for prostate cancer for men in all age groups; and be it further	74

RESOLVED, That the Clerk of the Senate transmit duly	75
authenticated copies of this resolution to each member of the Ohio	76
Congressional delegation.	77